Pharmaceutical Biotechnology - Drug Discovery and Clinical Applications
-
Author:
-
Subject:
-
Published by:Wiley-VCH
-
Published:06/02/2004
-
Price:$375.00
- < Buy this book >
The first part offers a comprehensive survey and review of the rapidly increasing array of biopharmaceuticals derived from the molecular biological approaches now widely available. This is followed by an extra section devoted to the very critical patenting and drug regulation issues. The whole is rounded off by detailed monographs of biotechnologically developed drugs that are already on the market.
Biography
Professor Müller is Head of the Department of Pharmaceutical Technology, Biotechnology & Quality Management at the Free University Berlin. His research focuses on solid lipid nanoparticles, nanosuspensions of poorly soluble drugs and drug targeting using the concept of "differential protein adsorption". He obtained his PhD at Kiel University in 1983, and spent 4 years as visiting scientist at the Pharmacy Department, University of Nottingham, UK and 1 year at the Université de Paris-Sud.
Table of Contents
Color Plates.
Part I. Introduction to Concepts and Technologies in Pharmaceutical Biotechnology.
1. A Primer on Pharmaceutical Biotechnology and Industrial Applications (Oliver Kayser, Rainer H. Müller).
2. Procaryotic and Eucaryotic Cells in Biotech Production (Stefan Pelzer, Dirk Hoffmeister, Irmgard Merfort, Andreas Bechthold).
3. Biopharmaceuticals Expressed in Plants (Jörg Knäblein
Part II. Industrial Development and Production Process.
4. Scientific, Technical and Economic Aspects of Vaccine Research and Development (Jens-Peter Gregersen).
5. DNA Vaccines: from Research Tools in Mice to Vaccines for Humans (Jeffrey Ulmer, John Donnelly, Jens-Peter Gregersen).
6. Characterization and Bioanalytical Aspects of Recombinant Proteins as Pharmaceutical Drugs (Jutta Haunschild, Titus Kretzschmar).
7. Biogeneric Drugs (Walter Hinderer).
Part III. Therapeutic Proteins – Special Pharmaceutical Aspects.
8. Pharmacokinetics and Pharmacodynamics of Biotech Drugs (Bernd Meibohm, Hartmut Derendorf).
9 Formulation of Biotech Products (Ralph Lipp, Erno Pungor).
10. Patents in the Pharmaceutical Biotechnology Industry: Legal and Ethical Issues (David B. Resnik).
11. Drug Approval in the European Union and the United States (Gary Walsh).
Part IV. Biotech 21 – Into the Next Decade.
12. Rituximab: Clinical Development of the First Therapeutic Antibody for Cancer (Antonio J. Grillo-López).
13. Somatic Gene Therapy – Advanced Biotechnology Products in Clinical Development (Matthias Schweizer, Egbert Flory, Carsten Muenk, Klaus Cichutek, Uwe Gottschalk).
14. Nonviral Gene Transfer Systems in Somatic Gene Therapy (Oliver Kayser, Albrecht F. Kiderlen).
15. Xenotransplanation in Pharmaceutical Biotechnology (Gregory J. Brunn, Jeffrey L. Platt).
16. Sculpturing the Architecture of Mineralized Tissues: Tissue Engineering of Bone from Soluble Signals to Smart Biomimetic Matrices (Ugo Ripamonti, Lentsha Nathaniel Ramoshebi, Janet Patton, June Teare, Thato Matsaba, Louise Renton).
Index.
- FTChange Management ProfessionalsNSW
- CCSAP PM ConsultantNSW
- CCSAP FICO ConsultantNT
- FTSAP Basis ConsultantACT
- FTSAP Basis ConsultantNSW
- FTQM Trainer and ConsultantNSW
- FTSales Account ManagerNSW
- FTSales Account ManagerNSW
- CCOBIEE ConsultantWA
- FTIT Account Manager - System Integrator - Career Progression - Start ImmediatelyNSW
- CCAPAC Campaign ManagerNSW
iAsset is a channel management ecosystem that automates all major aspects of the entire sales,marketing and service process, including data tracking, integrated learning, knowledge management and product lifecycle management.
In Search of the Long-Term Archiving Solution —Tape Continues to Be a Major Player
Tape technology’s speed, affordability, and reliability, as well as advances in physical tape digital storage technologies over the past ten years, keep it a major target in data centers worldwide. Learn about these advances and compare tape technologies with this free white paper from Spectra Logic.
Market Potential-Strategy Guide to the Active Archive Market
The active archive market is a growing segment where tape is seen as part of a disk or network fileystem. This means that to an end user disk and tape are “blended” and whether file is held on disk or tape is “invisible” to the end user. The active archive market is the fastest growing space in the storage industry and allows direct end user access to tape through a file system front end.

Buying Guides
Latest Products
- Microsoft previews new versions of Visual Studio and .Net
- Windows 8 hits its next milestone - Release Preview is out now
- Browser feature can be abused to misrepresent download origin, researcher says
- Fedora Linux capitulates to Microsoft boot certificate
- Windows 8 update: All the latest news, rumours and rumblings











